| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| R&D Expense | $16.5M | +6.4% |
| SG&A Expense | $9.6M | +142.5% |
| Operating Income | -$26.1M | -34.1% |
| Interest Expense | $5.0M | +248.1% |
| Pre-tax Income | -$99.9M | -308.8% |
| Income Tax | $17K | -22.7% |
| Net Income | -$99.9M | -308.5% |
| EPS (Basic) | $151.22 | +241.4% |
| EPS (Diluted) | $151.22 |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $81.5M | +298.9% |
| Current Assets | $85.4M | +278.3% |
| Total Assets | $87.0M | +263.7% |
| Current Liabilities | $5.3M | +3.0% |
| Total Liabilities | $14.5M | -69.5% |
| Stockholders' Equity | $72.5M | +194.6% |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.7M | -40.6% |
| Capital Expenditures | $318K | +107.8% |
| Investing Cash Flow | -$318K | -107.8% |
| Financing Cash Flow | $86.1M | +208.0% |
| Free Cash Flow | -$25.1M | -41.2% |
| +241.4% |